©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Regulation of Insulin-like Growth Factor-I Expression in Mouse Preadipocyte Ob1771 Cells (*)

(Received for publication, February 12, 1996; and in revised form, March 7, 1996)

Yasuki Kamai Satoshi Mikawa Keiji Endo Hiroshi Sakai Tohru Komano (§)

From the Laboratory of Biochemistry, Department of Agricultural Chemistry, Faculty of Agriculture, Kyoto University, Kyoto 606-01, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

In mouse preadipocyte Ob1771 cells, transcription of the insulin-like growth factor-I (IGF-I) gene was stimulated by growth hormone (GH), and IGF-I protein combined with GH in medium was required for their differentiation to adipocytes. During induction of the differentiation, the intracellular expression of each class of IGF-I mRNA was analyzed by reverse transcriptase-polymerase chain reaction. When the cells were cultured in the presence of GH, the class 1del. IGF-I mRNA was a major molecular species among IGF-I mRNAs. In the presence of both GH and IGF-I, the splicing pattern of IGF-I mRNA changed from class 1del. to class 1. Moreover, as detected by Western blotting, the IGF-I protein was present in cells and in the medium only when the cells were cultured in the presence of both GH and IGF-I. We found that IGF-I secreted from Ob1771 cells could act in an autocrine/paracrine fashion and induce the differentiation of other Ob1771 cells. It was demonstrated that the translation efficiency of class 1 mRNA was higher than that of class 1del. mRNA in vitro. These results suggested that stimulation with exogenous IGF-I in the presence of GH was required for the production of class 1 IGF-I mRNA and that the production of the IGF-I protein was activated by increasing the translation efficiency through shifting the splicing pattern of IGF-I mRNA from class 1del. to class 1. Exogenous IGF-I triggered the differentiation by initiating the synthesis of endogenous IGF-I.


INTRODUCTION

Insulin-like growth factor-I (IGF-I) (^1)is a 70-amino acid polypeptide similar to proinsulin(1) . Transcription of the IGF-I gene is regulated by growth hormone (GH), and IGF-I is thought to mediate many of the biological effects of GH(2, 3, 4, 5, 6) . IGF-I has insulin-like activities such as stimulation of glycogen synthesis (7) . IGF-I also functions as a mitogen and as a differentiation factor for various cell lines, including preadipocytes(8) . The biological actions of IGF-I begin by interaction with its cell surface receptor, which is a ligand-activable tyrosine-specific protein kinase similar to the insulin receptor(9) .

In mouse and rat(10, 11) , the IGF-I genes have two leader exons (exons 1 and 2), resulting in two kinds of mRNAs (classes 1 and 2) (11, 12, 13) . There is another mRNA species, class 1del., in which a central region of exon 1 is missing (Fig. 1A)(14, 15) . Exon 5 is also spliced alternatively, resulting in Ea encoded by exons 4 and 6 and Eb encoded by exons 4, 5, and 6(10, 16) . These diverse IGF-I mRNAs eventually give the same mature protein. The biological significance of the diversity of mRNAs, signal peptides, and E domains is not understood.


Figure 1: Structure of mouse IGF-I gene and expression of each class of IGF-I mRNAs during induction of differentiation. A, structure of mouse IGF-I gene is shown. Boxes indicate exons, and lines indicate introns and flanking regions. Solid boxes mark the coding region for the IGF-I prepropeptide, and a hatched box is the region spliced out, giving class 1del. mRNA. Half-arrows above the exons indicate positions and orientations of the primers used for RT-PCR. Three classes of mature mRNAs are also shown at the bottom of the panel. Ea and Eb are the splicing variants resulting from alternative splicing of exon 5. B, Ob1771 cells were grown to confluence in the standard medium (day 0) and cultured up to day 4 in the GH differentiation medium or in the GH-IGF-I differentiation medium. The medium was changed to the standard medium and the cells were cultured for 2 days. On the day indicated on top of the panel, total RNA was prepared from the cells. Using 1 µg of RNA, RT-PCR was done with primers 1 and 6 (class 1), with primers 1-1del. and 6 (class 1 + class 1del.), and with primers 2 and 6 (class 2). Amplified DNA fragments were analyzed by Southern hybridization as described under ``Experimental Procedures.'' Similar results were obtained in three independent experiments.



Mouse preadipocyte Ob1771 cells (17) can differentiate to adipocytes. GH has a strong adipogenic activity in Ob1771, 3T3-F442A(18, 19, 20) , and 3T3-L1 (21) preadipocytes. In Ob1771 cells, GH stimulates the formation of diacylglycerol(22) , modulates the transcription of the lipoprotein lipase gene (23) and transiently increase the transcription of the c-fos gene(22) . GH also stimulates the transcription of the IGF-I gene(6) , and IGF-I is thought to participate in inducing the differentiation. In differentiated Ob1771 cells, enzymes for lipid synthesis, such as glycerophosphate dehydrogenase (GPDH), are activated(24) .

Transcription of the IGF-I gene is stimulated by GH, but we observed that IGF-I combined with GH was essential for the differentiation of Ob1771 cells. The following interpretations are possible for these facts. (i) For some reason, IGF-I secreted from Ob1771 cells is not active enough to induce the differentiation. (ii) The IGF-I mRNA is translated when cells are cultured in the presence of both GH and IGF-I, but not when cells are cultured in the presence of GH alone. (iii) The IGF-I protein is not secreted from Ob1771 cells without the signal from the IGF-I receptor. To examine these possibilities, we analyzed the expression of each class of IGF-I mRNA, and the expression and secretion of IGF-I protein during the induction of differentiation. Furthermore, we examined the translation efficiency of class 1 and class 1del. mRNAs in vitro. In this study we show that IGF-I in the medium changed the splicing pattern of IGF-I mRNA and allowed the synthesis of IGF-I protein.


EXPERIMENTAL PROCEDURES

Cell Culture

Ob1771 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 200 units of penicillin/ml, 50 µg of streptomycin/ml, 33 µM biotin, 17 µM pantothenate, and 10% (v/v) calf serum (Sigma). This medium was termed the standard medium. At confluence (day 0), cells were exposed to the standard medium supplemented with 2 nM triiodothyronine (Sigma) and 100 µM 3-isobutyl-1-methylxanthine (Sigma), which was termed the differentiation medium. If necessary, cells were cultured from day 0 to day 4 in the differentiation medium that was supplemented with 10 nM recombinant goat GH purified from Escherichia coli and/or with 10 nM recombinant human IGF-I (Bachem). The differentiation media supplemented with GH, or with both GH and IGF-I, were termed the GH differentiation medium and the GH-IGF-I differentiation medium, respectively. Cells were cultured in the standard medium for 4 additional days (day 8) and used for the GPDH assay. Both the standard medium and the differentiation medium were changed every 2 days.

To obtain conditioned media and cell lysates for Western blotting, cells were incubated in the serum free medium, ASF104 (Ajinomoto), for 24 h. After the medium was removed, the cells were harvested in the lysis buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM EDTA, 0.5 mM (p-amidinophenyl)methanesulfonyl fluoride hydrochloride, 2 mM benzamidine, 165 KIU/ml aprotinin, and 1% Nonidet P-40.

GPDH Assay

After induction of the differentiation (day 8), the cells were harvested and the GPDH activity was assayed as described previously (25, 26, 27, 28) by measurement of oxidation of NADH based on the absorbance at 340 nm. Two independent experiments were performed.

RT-PCR and Southern Hybridization

For detection of both class 1 and class 1del. mRNAs, we prepared primer 1-1del. (ATGGGGAAAATCAGCAGTC), the nucleotide sequence of which appears in exon 1. For exclusive detection of class 1 mRNA, we prepared primer 1 (TCAAAATTGAAATGTGAC), the nucleotide sequence of which appears in the region of exon 1 that is to be removed upon splicing to form class 1del. mRNA. For detection of class 2 mRNA, we prepared primer 2 (CTGCTGTGTAAACGACCCGG), the nucleotide sequence of which appears in exon 2. We also prepared primer 6 (AGGTCTTGTTTCCTGCAC), the nucleotide sequence of which appears in the complementary strand in exon 6 (Fig. 1A). Total RNA was prepared from cells by acid-guanidine thiocyanate-phenol-chloroform methods(29) . One microgram of the total RNA was transcribed into cDNA with 200 units of reverse transcriptase from murine leukemia virus (Life Technologies, Inc.) in 20 µl of a reaction mixture containing 50 mM KCl, 20 mM Tris-Cl (pH 8.4), 2.5 mM MgCl(2), 0.1 mg/ml bovine serum albumin, 1 mM each dNTP, 5 mM random hexamer, and 20 units of the ribonuclease inhibitor RNasin (Promega). The cDNA synthesized during incubation for 1 h at 42 °C was used as a template for PCR in a reaction mixture containing 5 units of Taq DNA polymerase, 50 mM KCl, 20 mM Tris-Cl (pH 8.4), 2.5 mM MgCl(2), 0.1 mg/ml bovine serum albumin, 0.2 mM each dNTP, and 0.2 mM each of the two primers. After 25 cycles (1 min at 95 °C, 1 min at 55 °C, and 2 min at 72 °C) of the PCR, DNA fragments were electrophoresed on a 1% agarose gel and transferred to GeneScreen Plus. Hybridization was done using the mouse IGF-I cDNA as a probe, and positive signals were detected with a ECL labeling and detection system (Amersham Corp.).

Western Blotting

Cell lysates and conditioned media were separated on a 15% SDS-polyacrylamide gel and transferred to cellulose nitrate membranes (Schleicher & Schuell). The membrane was blocked for 2 h in PBS containing 0.1% Tween 20 (PBS-T) with 5% skim milk (Difco) and incubated for 1 h with monoclonal anti-human insulin-like growth factor-I antibody (Upstate Biotechnology, Inc.) in PBS-T. The membrane was washed twice for 15 min with PBS-T and incubated for 1 h with goat anti-mouse IgG antibody horseradish peroxidase conjugate (Bio-Rad) in PBS-T. After washing, the bound antibody was made visible using an ECL detection system (Amersham).

In Vitro Transcription and in Vitro Translation

Plasmid constructs that contained the cDNAs for mouse IGF-I class 1 and class 1del. mRNAs at the BamHI site of pBluescript II KS were linearized and transcribed in vitro using T7 RNA polymerase. Messenger RNAs were synthesized in the presence of 0.3 mM of the cap analogue m7GpppG (New England Biolabs). In vitro translation of four micrograms each of in vitro transcribed IGF-I mRNAs was done according to the manufacture's instructions (Amersham) in rabbit reticulocyte lysates containing biotin-Lys-tRNA. The decay of individual mRNAs during in vitro translation was examined by Northern blotting. Newly synthesized biotinylated proteins were separated on a 13% SDS-polyacrylamide gel and transferred to cellulose nitrate membranes. The membrane was probed with horseradish peroxidase-labeled streptoavidin (Amersham), and the bound streptoavidin was made visible using an ECL detection system.


RESULTS AND DISCUSSION

Requirement of GH and IGF-I for the Differentiation of Ob1771 Cells

Based on the activation of GPDH, we analyzed the differentiation of post-confluent Ob1771 cells that had been cultured in the GH differentiation medium and in the GH-IGF-I differentiation medium. In the differentiation medium with no supplement, Ob1771 cells did not differentiate and GPDH was not activated. Cells that had been cultured in the GH-IGF-I differentiation medium differentiated to adipocytes; GPDH was markedly activated and many intracellular oil droplets were observed. With the cells cultured in the GH differentiation medium, the GPDH activity was only 5.8% of that of the cells cultured in the GH-IGF-I differentiation medium (data not shown). This showed that exogenous IGF-I combined with GH was essential for the differentiation of Ob1771 cells.

Formation of Each Class of IGF-I mRNA during Induction of the Differentiation

In Ob1771 cells, it was reported that transcription of the IGF-I gene was stimulated by GH(6) . Here we analyzed the formation of each class of mRNA when post-confluent Ob1771 cells were cultured in the GH differentiation medium or in the GH-IGF-I differentiation medium. Total RNA was prepared from the cells, and the formation of each class of mRNA was analyzed by RT-PCR (Fig. 1B). In the GH differentiation medium, class 1del. mRNA was a major molecular species. In the GH-IGF-I differentiation medium, the splicing pattern was changed, resulting in the formation of class 1 mRNA. In both cases, class 2 mRNA was expressed transiently on the 4th day in the course of induction. This result strongly suggested that splicing in exon 1 of the IGF-I gene was regulated by IGF-I itself.

Requirement of Both GH and IGF-I for the Synthesis and Secretion of IGF-I Protein

Post-confluent Ob1771 cells were cultured in the GH differentiation medium or in the GH-IGF-I differentiation medium, and the synthesis and secretion of the IGF-I protein were analyzed. Cell lysates and conditioned media were separated by SDS-polyacrylamide gel electrophoresis and the IGF-I protein was detected by Western blotting using anti-IGF-I antibody (Fig. 2). Neither the cells nor the conditioned medium contained the IGF-I protein when the cells had been cultured in the GH differentiation medium. The IGF-I protein was found in the cells from day 2 to day 4 when the cells had been cultured in the GH-IGF-I differentiation medium. In this case, IGF-I was found to be secreted from the cells. On day 4, the medium was changed to the standard medium that did not contain GH and IGF-I. On day 6, synthesis and secretion of IGF-I did not stop immediately and IGF-I was detected both in the cells and in the medium.


Figure 2: Secretion and production of IGF-I. Ob1771 cells were cultured to confluence in the standard medium (day 0) and cultured up to day 4 in the differentiation medium supplemented with 10 nM GH (GH) or with 10 nM GH and 10 nM IGF-I (GH + IGF-I). The medium was changed to the standard medium, and the cells were cultured for 2 days. On the day indicated on top of the panel, the medium was changed to the serum-free medium, and the cells were cultured for 24 h. The cells and the media were collected separately and the IGF-I proteins in them were analyzed by Western blotting using the mouse anti-human IGF-I monoclonal antibody as described under ``Experimental Procedures.'' Similar results were obtained in three independent experiments.



Post-confluent Ob1771 cells were cultured for 2 days in the GH differentiation medium or in the GH-IGF-I differentiation medium followed by the maintenance for 1 day in the differentiation medium with no supplement, and a medium was finally obtained which was termed the GH conditioned medium or the GH-IGF-I conditioned medium, respectively. To analyze the activity of the secreted IGF-I, we examined the differentiation of another mass of Ob1771 cells with these two kinds of conditioned media based on the activation of GPDH. When the cells were cultured in the GH-IGF-I conditioned medium supplemented with 10 nM GH, the increment of the GPDH activity was 82% of that of fully differentiated cells cultured in the GH-IGF-I differentiation medium, and when the cells were cultured in the GH conditioned medium with GH, the increment of the GPDH activity was 17% of that of fully differentiated cells (data not shown). These results showed that the IGF-I protein secreted from Ob1771 cells had an activity that induced the differentiation of another mass of Ob1771 cells.

Translation Efficiency of IGF-I mRNAs in Vitro

These results demonstrated that exogenous IGF-I changed the splicing pattern of IGF-I mRNA from class 1del. to class 1 and that exogenous IGF-I was also required to synthesize endogenous IGF-I. These results suggested that the class 1 mRNA was engaged in the synthesis of IGF-I protein, and the class 1del. mRNA was translationally inactive. To confirm this, we examined the translation efficiency of class 1 and class 1del. mRNAs by the in vitro translation assay (Fig. 3). With the rat class 1 IGF-I mRNA, several transcriptional initiation sites of exon 1 were reported(30) . Here we obtained two class 1 mRNAs, starting at 252 and 303 nucleotides upstream from the 3` end of exon 1 and a class 1del. mRNA starting at 177 nucleotides upstream of the 3` end of the truncated exon 1 that lacked the central region through splicing. The amounts of translation products of class 1 mRNAs starting at 252 and 303 nucleotides upstream from the 3` end of exon 1 were 29.4- and 13.7-fold greater than that of class 1del. mRNA, respectively. This result demonstrated that class 1del. mRNA is much less active in translation in vitro than the class 1 mRNAs and suggested that the inactivity of class 1del. mRNA is caused by some structural elements in the RNA molecule. Thus, translationally inactive class 1del. mRNA most probably results in little production of the endogenous IGF-I protein in Ob1771 cells in the GH differentiation medium.


Figure 3: Translation efficiency of class 1 and class 1del. mRNAs in vitro. Class 1 mRNAs starting at 303 (lane 2) and 252 (lane 3) nucleotides upstream from the 3` end of exon1 and class 1del. mRNA (lane 4) were transcribed in vitro and in vitro translation of four micrograms each of mRNAs was performed in rabbit reticulocyte lysates containing biotin-Lys-tRNA. Biotinylated proteins were analyzed by Western blotting using horseradish peroxidase-labeled streptoavidin as described under ``Experimental Procedures.'' Lane 1 indicates a blank reaction without added mRNA. Similar results were obtained in three independent experiments.



Regulation of the IGF-I Gene Expression and the Differentiation of Ob1771 Cells

The results in this paper demonstrated that the IGF-I gene expression was regulated post-transcriptionally by IGF-I itself. In the case of insulin, it was reported that insulin regulated the expression of some genes post-transcriptionally. For example, insulin combined with thrombin stabilizes c-myc mRNA (31) , and insulin regulates the relative level of expression of the two mRNA variants of the highly insulin-induced delayed early gene, hrs, in differentiating H35 cells(32) . Insulin also regulates the alternative splicing of exon 11 of the insulin receptor gene in FAO cells (33) and of the protein kinase Cbeta in BC3H-1 myocytes(34) . Here we demonstrated that exogenous IGF-I changed the splicing pattern of IGF-I mRNA from class 1del. to class 1 in Ob1771 cells. In addition, when the cells were cultured in the GH differentiation medium, class 1del. mRNA appeared in two bands in the Southern hybridization analysis of the DNA fragments amplified by RT-PCR (Fig. 1B). It is suggested that the upper and the lower bands reflect the mRNA species, including and excluding exon 5, respectively (Fig. 1A). Thus, the alternative splicing of exon 5 is also regulated by IGF-I. However, the significance of this regulation is not clear. Although the growth factor-dependent regulation of the alternative splicing has not been reported, it is likely that IGF-I regulates factors involved in the alternative pre-mRNA splicing.

In our studies, class 1 mRNA was proved to be more efficiently translated into protein than class 1del. mRNA in vitro. This suggests that exogenous IGF-I activates the intracellular production of IGF-I protein by shifting the splicing pattern of IGF-I mRNA from class 1del. to class 1, which is much more active in translation. The present result also suggests the presence of specific cis-elements involved in the translational control. It is reported that the efficiency of translation initiation is affected by the sequence context near the 5` cap(35) , by the upstream AUG codons and by the length and secondary structure of the mRNA leader(36) . Further studies are necessary to identify specific elements involved in the translational regulation of IGF-I mRNA. However, we cannot rule out the possibility that exogenous IGF-I also activates cellular translation machinery in vivo.

In Ob1771 cells, class 2 mRNA may be translationally inactive, since the time of its appearance and requirement of GH and IGF-I do not coincide with those for the IGF-I production. However, it is possible that class 2 mRNA is translationally regulated in different ways specified by cell types and growth stages.

We found that the GH-IGF-I conditioned medium, which contained IGF-I secreted from Ob1771 cells, had an activity that induced the differentiation of other Ob1771 cells. It is strongly suggested that the activity was attributed to IGF-I in the medium. However, we cannot rule out the possibility that another adipogenic factor is secreted from Ob1771 cells in the presence of GH combined with IGF-I and regulates the differentiation. Thus, we propose the following hypothesis. GH stimulates the transcription of the IGF-I gene, but the produced mRNA is mainly class 1del. mRNA, which is not efficiently translated into protein. Exogenous IGF-I acts on preadipocytes in an endocrine fashion to initiate the differentiation and also to initiate the synthesis and secretion of endogenous IGF-I, which then acts in an autocrine fashion and stimulates the next round of the production and secretion of endogenous IGF-I. Therefore once endogenous IGF-I was produced and secreted, exogenous IGF-I may not be needed any more in the medium. An Ob1771 cell stimulated by IGF-I combined with GH synthesizes and secretes many IGF-I molecules, which act on other Ob1771 cells in a paracrine fashion. Amplified IGF-I acts on a large number of cells and induces the differentiation and synthesis of IGF-I to a progressively greater extent. In this way, many cells can differentiate into adipocytes in response to the initial stimulation with IGF-I. Although it is not clear whether a similar mechanism regulates the expression of the IGF-I gene in other cell types, it is possible that one of the post-transcriptional control mechanisms of the IGF-I gene expression is the exogenous IGF-I-dependent regulation of alternative splicing of pre-mRNA


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Laboratory of Biochemistry, Dept. of Agricultural Chemistry, Kyoto University, Kyoto 606-01, Japan. Tel.: 81-75-753-6124; Fax: 81-75-753-6104.

(^1)
The abbreviations used are: IGF-I, insulin-like growth factor-I; GH, growth hormone; GPDH, glycerophosphate dehydrogenase; RT-PCR, reverse transcriptase-polymerase chain reaction; PBS, phosphate-buffered saline.


ACKNOWLEDGEMENTS

We thank Dr. G. Ailhaud and Dr. T. Kawada for providing us with Ob1771 cells


REFERENCES

  1. Blundell, T. L., Bedarker, S., Rinderknecht, E., and Humbel, R. E. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 180-184 [Abstract]
  2. Mathews, L. S., Norstedt, G., and Palmiter, R. D. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 9343-9347 [Abstract]
  3. Schoenle, E., Zapf, J., Humbel, R. E., and Froesch, E. R. (1982) Nature 296, 252-253 [Medline] [Order article via Infotrieve]
  4. Isaksson, O. G. P., Jansson, J. O., and Gause, I. A. M. (1982) Science 216, 1237-1239 [Medline] [Order article via Infotrieve]
  5. Froesch, E. R., Schmidt, C., Schwander, J., and Zapf, J. (1985) Annu. Rev. Physiol. 47, 443-467 [CrossRef][Medline] [Order article via Infotrieve]
  6. Doglio, A., Dani, C., Fredrikson, G., Grimaldi, P., and Ailhaud, G. (1987) EMBO J. 6, 4011-4016 [Abstract]
  7. Zapf, J., Shoenle, E., and Froesch, E. R. (1978) Eur. J. Biochem. 87, 285-296 [Medline] [Order article via Infotrieve]
  8. Schmidt, W., Pøll-Jordan, G., and Loffler, G. (1990) J. Biol. Chem. 265, 15489-15495 [Abstract/Free Full Text]
  9. Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E., Jacobs, S., Francke, U., Ramachandran, J., and Fujita-Yamaguchi, Y. (1986) EMBO J. 5, 2503-2512 [Abstract]
  10. Shimatsu, A., and Rotwein, P. (1987) J. Biol. Chem. 262, 7894-7900 [Abstract/Free Full Text]
  11. Bucci, C., Mallucci, P., Roberts, C. T., Frunzio, R., and Brunni, C. B. (1989) Nucleic Acids Res. 17, 3596 [Medline] [Order article via Infotrieve]
  12. Roberts, C. T., Jr., Lacky, S. R., Lowe, W. L., Jr., and LeRoith, D. (1987) Biochem. Biophys. Res. Commun. 146, 1154-1159 [Medline] [Order article via Infotrieve]
  13. Casella, S. J., Smith, E. P., Van Wyk, J. J., Joseph, D. R., Hynes, M. A., Hoyt, E. C., and Lund, P. K. (1987) DNA (N. Y.) 6, 325-330
  14. Shimatsu, A., and Rotwein, P. (1987) Nucleic Acids Res. 15, 7196 [Medline] [Order article via Infotrieve]
  15. Foyt, H. L., LeRoith, D., and Roberts, C. T., Jr. (1991) J. Biol. Chem. 266, 7300-7305 [Abstract/Free Full Text]
  16. Roberts, C. T., Jr., Lacky, S. R., Lowe, W. L., Jr., Seaman, W. T., and LeRoith, D. (1987) Mol. Endocrinol. 1, 243-248 [Abstract]
  17. Amri, E., Dani, C., Doglio, A., Etienne, J., Grimaldi, P., and Ailhaud, G. (1986) Biochem. J. 238, 115-122 [Medline] [Order article via Infotrieve]
  18. Morikawa, M., Nixon, T., and Green, H. (1982) Cell 29, 783-789 [Medline] [Order article via Infotrieve]
  19. Nixon, T., and Green, H. (1984) Endocrinology 114, 527-532 [Abstract]
  20. Zezulak, K. M., and Green, H. (1986) Science 233, 551-553 [Medline] [Order article via Infotrieve]
  21. Hauner, H., and Loffler, G. (1986) Int. J. Obes. 10, 323-330 [Medline] [Order article via Infotrieve]
  22. Doglio, A., Dani, C., Grimaldi, P., and Ailhaud, G. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 1148-1152 [Abstract]
  23. Pradines-Figuéres, A., Barcellini-Couget, S., Dani, C., Vannier, C., and Ailhaud, G. (1990) J. Lipid Res. 31, 1283-1291 [Abstract]
  24. Doglio, A., Dani, C., Grimaldi, P., and Ailhaud, G. (1986) Biochem. J. 238, 123-129 [Medline] [Order article via Infotrieve]
  25. Kuri-Harcuch, W., Wise, L. S., and Green, H. (1978) Cell 14, 53-59 [Medline] [Order article via Infotrieve]
  26. Wise, L. S., and Green, H. (1979) J. Biol. Chem. 254, 273-275 [Abstract]
  27. Pairault, J., and Green, H. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 5138-5142 [Abstract]
  28. Kozak, L. P., and Jensen, J. T. (1974) J. Biol. Chem. 249, 7775-7781 [Abstract/Free Full Text]
  29. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  30. Adamo, M. L., Ben-Hur, H., LeRoith, D., and Roberts, C. T., Jr. (1991) Biochem. Biophys. Res. Commun. 176, 887-893 [Medline] [Order article via Infotrieve]
  31. Blanchard, J.-M., Piechazyk, M., Dani, C., Chambard, J.-C., Franchi, A., Pouyssegur, J., and Jeanteur, P. (1985) Nature 317, 443-445 [Medline] [Order article via Infotrieve]
  32. Diamond, R. H., Du, K., Lee, V. M., Mohn, K. L., Haber, B. A., Tewari, D. S., and Taub, R. (1993) J. Biol. Chem. 268, 15185-15192 [Abstract/Free Full Text]
  33. Sell, S. M., Reese, D., and Ossowsli, V. M. (1994) J. Biol. Chem. 269, 30769-30772 [Abstract/Free Full Text]
  34. Chalfant, C. E., Mischak, H., Watson, J. E., Winkler, B. C., Goodnight, J., Farese, R. V., and Cooper, D. R. (1995) J. Biol. Chem. 270, 13326-13332 [Abstract/Free Full Text]
  35. Jeffries, H. B. J., Reinhard, C., Kozma, S. C., and Thomas, G. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 4441-4445 [Abstract]
  36. Hershey, J. W. B. (1991) Annu. Rev. Biochem. 60, 717-755 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.